相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biological Cleavage of the C-P Bond in Perfluoroalkyl Phosphinic Acids in Male Sprague- Dawley Rats and the Formation of Persistent and Reactive Metabolites
Shira Joudan et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2017)
Improved Tumor Uptake by Optimizing Liposome Based RES Blockade Strategy
Xiaolian Sun et al.
THERANOSTICS (2017)
Cancer Statistics, 2017
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Folic acid tagged nanoceria as a novel therapeutic agent in ovarian cancer
Miriana Hijaz et al.
BMC CANCER (2016)
In vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatin
Merlis P. Alvarez-Berrios et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Anti-transferrin receptor-modified amphotericin B-loaded PLA-PEG nanoparticles cure Candidal meningitis and reduce drug toxicity
Xiaolong Tang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2015)
Enhanced effect of photodynamic therapy in ovarian cancer using a nanoparticle drug delivery system
Zhao Li et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Nanomedicine in cancer therapy: Challenges, opportunities, and clinical applications
Andreas Wicki et al.
JOURNAL OF CONTROLLED RELEASE (2015)
被撤回的出版物: Targeted immune therapy of ovarian cancer (Retracted article. See vol. 35, pg. 489, 2016)
Keith L. Knutson et al.
CANCER AND METASTASIS REVIEWS (2015)
Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapy
Luis Novo et al.
JOURNAL OF CONTROLLED RELEASE (2014)
Colloidal nanoparticles as advanced biological sensors
Philip D. Howes et al.
SCIENCE (2014)
Targeted drug delivery via folate receptors in recurrent ovarian cancer: a review
Claudia Marchetti et al.
ONCOTARGETS AND THERAPY (2014)
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
Mark J. Ernsting et al.
JOURNAL OF CONTROLLED RELEASE (2013)
OA02 Peptide Facilitates the Precise Targeting of Paclitaxel- Loaded Micellar Nanoparticles to Ovarian Cancer In Vivo
Kai Xiao et al.
CANCER RESEARCH (2012)
Serous ovarian carcinoma patients with high alpha-folate receptor had reducing survival and cytotoxic chemo-response
Yu-Li Chen et al.
MOLECULAR ONCOLOGY (2012)
A Folate Receptor-Targeting Nanoparticle Minimizes Drug Resistance in a Human Cancer Model
Xu Wang et al.
ACS NANO (2011)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Randomized Phase III Study of Canfosfamide in Combination With Pegylated Liposomal Doxorubicin Compared With Pegylated Liposomal Doxorubicin Alone in Platinum-Resistant Ovarian Cancer
Ignace Vergote et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
Follicle-Stimulating Hormone Peptide Can Facilitate Paclitaxel Nanoparticles to Target Ovarian Carcinoma In vivo
Xiao-yan Zhang et al.
CANCER RESEARCH (2009)
Folate-targeted therapeutic and imaging agents for cancer
Philip Stewart Low et al.
CURRENT OPINION IN CHEMICAL BIOLOGY (2009)
Improved survival time: What can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer?
Lan Huang et al.
CANCER (2008)
Randomized phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer
David G. Mutch et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Amphiphilic poly(D,L-lactic acid)/poly(ethylene glycol)/poly(D,L-lactic acid) nanogels for controlled release of hydrophobic drugs
Wen-Chuan Lee et al.
MACROMOLECULAR BIOSCIENCE (2006)
Role of folate receptor genes in reproduction and related cancers
H Elnakat et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Phototoxicity of Hemoporfin to ovarian cancer
K Song et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
S Sengupta et al.
NATURE (2005)
Formation and degradation of poly(D,L-lactide) nanoparticles and their potential application as controllable releasing devices
Y Zhao et al.
MACROMOLECULAR BIOSCIENCE (2004)
Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study
RF Ozols et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Control of degradation rate and hydrophilicity in electrospun non-woven poly(D,L-lactide) nanofiber scaffolds for biomedical applications
K Kim et al.
BIOMATERIALS (2003)
分享论文
